Application of affine cudweed or extract of affine cudweed in preparation of medicine for treating viral pneumonia

The invention provides application of affine cudweed or an extract thereof in preparation of a medicine for treating viral pneumonia. The affine cudweed ethanol extract has the advantages that the affine cudweed ethanol extract is clear in medicine effect, safe and controllable when being used for treating viral pneumonia, and the affine cudweed ethanol extract has the advantages that the number of neutrophils and macrophages related to inflammation is remarkably reduced; the expression of key inflammatory factors (IL-1beta and TNF-alpha) is obviously reduced; the compound has broad-spectrum and efficient antiviral activity, and provides a new choice for clinic..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 07. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

YE XIANGLI [VerfasserIn]
CHEN XIANGQI [VerfasserIn]
CHEN LIMIN [VerfasserIn]
HUANG ZHENGHUI [VerfasserIn]
LIN QIONG [VerfasserIn]
LIU WANTING [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che
G01N: Investigating or analysing materials by determining (...)
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-07, Last update posted on www.tib.eu: 2024-01-29, Last updated: 2024-02-02

Patentnummer:

CN116999475

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA019106270